Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

NCT02954575 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hemophilia A

Interventions

DRUG: Wilate

Sponsor

Octapharma